Clinical Trial

Brain Connectivity Changes in Glioma Patients During Treatment

Study acronym: GliRecon
Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this observational study is to better understand how the brain changes during the treatment of glioma. In particular, the study looks at changes in important brain areas that are responsible for functions such as movement, language, or sensation, as well as the nerve fiber pathways that connect these areas. The main question this study aims to answer is: How do important brain areas and their connections adapt and reorganize over the course of glioma treatment? Patients with glioma will undergo repeated brain imaging examinations as part of their regular medical care. These images will be analyzed over time to observe changes in brain activity and structure during different stages of therapy. By studying these changes, researchers hope to gain new insights into the brain's ability to adapt (neuroplasticity) throughout the entire course of glioma treatment.
Trial Details
NCT Number NCT07612917
Lead Sponsor Johannes Kepler University of Linz
Collaborators: Clinical Research Institute for Neurosciences, JKU Linz, Austria, Institute of Neuroradiology, Kepler University Hospital, Johannes Kepler University, Linz, Department of Neurosurgery, Kepler University Hospital, Johannes Kepler University Linz, Department of Radiation Oncology, Ordensklinikum Linz, Barmherzige Schwestern, Linz
Conditions Glioma (Any Grade) in the Brain, Gliomas, Malignant, fMRI Research, Neurocognitive Function
Enrollment 20 participants
Start Date 2026-05-01
Primary Completion 2029-09 (estimated)
Study Completion 2029-12 (estimated)
Updated on ClinicalTrials.gov 2026-08-13